Researchers analyzed the effects of small-molecule drugs on colorectal tumor cells, finding that treatment with Imipridones decreased certain cytokines and increased others. The study highlights the complexity of cytokine signaling and its potential as a biomarker for diagnosis and prognosis in colon cancer.
The study proposes a new approach to inhibit MYC's essential interaction with TRRAP, a protein required for efficient histone acetylation. This disruption could lead to cancer-specific targeted therapies with minimal effects on normal cells.
This case-control study suggests that TP53 somatic mutations detected by next-generation sequencing are associated with an adverse prognosis in breast cancer. Co-existence of PIK3CA mutation was a common finding in TP53-mutant tumors.
A study found that prolyl oligopeptidase inhibition with KYP-2047 treatment reduces collagen amount and lowers inflammatory protein levels in lung tissue. The treatment also modulates apoptosis, preserving lung function after intestinal ischemia-reperfusion injury.
Research associates gray matter and white matter neurodegeneration with subjective cognitive complaints, highlighting potential non-AD pathologies. Neurodegeneration processes affect brain areas not typically targeted by Alzheimer's disease.
Researchers used CRISPR/dCas9 technology to target DNA methylation and study its effects on cancer cell behavior. The study found that the same epigenetic modification can lead to opposing expression profiles of a target gene in different cancer cell models.
Researchers used Caenorhabditis elegans to detect very-early-stage pancreatic cancer, achieving a reported sensitivity of 95.8%. The method showed promise for use in detecting patients with early PDAC, but the underlying mechanisms need further clarification.
A study published in Aging-US reveals that protein processing impairment in Parkinson's disease is mediated by chromogranin/secretogranin, leading to decreased candidate proteins and peptides. This finding suggests a potential therapeutic target for the treatment of PD.
Researchers have identified a significant association between periodontal disease, oral pathogens, and the development of gastric cancer. The study suggests that individuals with gastric cancer have a higher prevalence of oral pathogens, which may contribute to the risk of developing the disease.
Research investigates m6A regulators in cognitive dysfunctions, identifying potential biomarkers like SNRPG and SNRPD2. The study also highlights the role of APOE ε4 allele and FTO expression in AD development.
Researchers found that high CD39 expression is associated with human bladder cancer, particularly in the non-muscle-invasive phenotype. CD39's involvement in tumor development and progression is still unclear, but its overexpression in early-stage tumors suggests a potential role in bladder cancer progression.
Recent studies suggest that aging is a malleable process influenced by physiological, genetic, dietary, and pharmaceutical interventions. The relationship between cellular senescence and immunosenescence has been largely explored, with the goal of developing improved therapeutics to conserve vitality as we age.
The study found no significant causal relationship between genetically determined age at menarche or menopause and AD risk. However, an inverse association was detected between age at menarche and body mass index. Further studies are needed to validate these findings.
Researchers discovered that cellular senescent cells exhibit hyper-activation in response to inflammatory stimuli, leading to increased expression of inflammatory cytokines and chemokines. This phenomenon contributes to the age-related predisposition to severe infections and inflammation.
Leiomyosarcomas are diverse, rare, and aggressive mesenchymal soft tissue sarcomas. Epigenetic profiling identified differential DNA methylation and gene expression patterns associated with subtypes. These findings suggest epigenetic profiles can be used to stratify patients and apply targeted therapies.
Ablative radioembolization has been found to have a high response rate and promising survival in patients with unresectable intrahepatic cholangiocarcinoma. The study also showed that the treatment is well-tolerated, with median overall survival not reached at 30 months.
Researchers evaluated the anti-tumor efficacy of DARA conjugated to DM1 via a non-cleavable linker, demonstrating enhanced therapeutic potency and in vivo stability. The study showed that conjugation did not affect the stability or activity of the biologic, and imaging techniques can be applied to other immunotherapies.
Researchers have developed a novel immunotherapy approach using PBMCs to generate TEM/TCM cells for adoptive cell therapy in multiple myeloma. The treatment targets WT1-specific cytotoxic T lymphocytes, which show high sensitivity to MM cells, providing a promising basis for an additional therapeutic strategy.
A new study compared the molecular profiles of lung cancer cells grown in 3D and 2D cultures, finding significant differences in protein expression and regulation. The research used a membrane proteomics approach to analyze the NCI-H23 cell line and identified exclusive expressions of CD molecules in 3D culture.
The study reveals vast differences in gene expression and cytokine response across different chemotherapy agents, shedding light on their mechanisms of efficacy and toxicity in colorectal cancer. The findings contribute to the understanding of molecular bases of response in CRC tumors exposed to these drugs.
Researchers report that pevonedistat inhibits NEDD8-activating enzyme, leading to cell cycle arrest and anaphase catastrophe in malignant T-cells. This effect may be coupled with immunomodulatory activity, suggesting pevonedistat as a potential therapeutic approach for T-cell lymphoma.
Researchers found low T cell infiltration in glioblastoma tissue, with higher CD8+ TIL density at recurrence. The study suggests that immune checkpoint inhibition may not be effective due to limited tumour-infiltrating lymphocyte density.
Researchers discovered that four terpyridine platinum compounds induce telomere dysfunction, leading to high levels of chromosome instability. This study provides promising leads for cancer treatment using these compounds alone or in combination with ionizing radiation.
The study found that NEAT1 lncRNA interacts with JunD to regulate tight junction assembly and promote EMT induction in head and neck cancer cells. Increased NEAT1 expression correlates with poor disease prognosis.
Researchers explored exosomal markers CD63 and CD9 in rectal adenocarcinoma. Higher expressions correlated with high NAR scores, suggesting prognostic significance. Neoadjuvant chemoradiation impact on exosomal marker expression was found, warranting further studies.
Researchers discovered downregulated immune responses and upregulated T cell-exhaustion pathways in African American patients compared to European Americans. These findings suggest striking differences in immunoregulatory gene activities that may contribute to the worse prognosis of prostate cancer in Black Americans.
The study found that DNMT2/TRDMT1 gene knockout can affect the responses to senescence-inducing concentrations of doxorubicin and etoposide in different cancer cells. This may lead to diverse outcomes based on the type of cancer cells and anti-cancer drugs used.
A study in HNSC patients found that specific microRNAs, such as hsa-miR-203a-3p, mir-10a-5p, and miR-194-5p, are strongly associated with lymphovascular invasion (LVI). These miRNAs regulate biological pathways involved in tumor progression, making them potential prognostic indicators.
Researchers found that early life irradiation-induced γH2AX foci persisted in adult mice, leading to brain aging and shortened lifespan. The study suggests a potential link between early life radiation exposure and later-stage neurodegenerative disorders.
Researchers have developed a novel model of the aged lung epithelium in idiopathic pulmonary fibrosis (IPF), a devastating age-related lung disease. The model, which replicates IPF-like changes in mouse cells, holds promise for uncovering new biological mechanisms and testing novel pharmacological compounds to treat the disease.
Researchers used a comprehensive knowledgebase to identify 22 actionable genes and 43 candidate drugs for biliary tract cancer, which may lead to the development of targeted therapies. The study's findings contribute to personalized treatment options for this rare tumor worldwide.
Researchers developed a new cancer therapy combining sulforaphane (SFN) and acetazolamide (AZ), which inhibits the PI3K/Akt/mTOR survival pathway and reduces 5-HT secretion in carcinoid syndrome. The combination therapy induces apoptosis in tumor cells, upregulates the p21 cell cycle inhibitor, and downregulates the PI3K/Akt/mTOR pathway.
A randomized controlled trial found that facility-based and home-based multidomain interventions improved cognitive function and retention rates among participants aged 60-79. The programs showed indicators of efficacy and feasibility, with potential benefits through inactivation of the HPA axis and enhanced brain plasticity.
This study characterizes the aging-associated miRNA profile in murine cardiac fibroblasts, revealing a significant decrease in miRNAs generated by the Meg3-Mirg locus. The findings suggest that this repression is a common feature of aging across multiple organs, highlighting the robustness of miRNA modulation during this process.
Researchers investigate G-quadruplex stabilization in neurons, astrocytes, and microglia, revealing differences in genomic instability and DNA repair pathways. These findings suggest that stabilized G4s contribute to brain aging and neurodegeneration.
Researchers found that Antrodia salmonea induces apoptosis and enhances cytoprotective autophagy in colon cancer cells, suggesting a potential treatment for colon cancer. The study reveals that AS-induced apoptosis and autophagy are mediated by reactive oxygen species.
The study found that PirB expression increased with age and inhibited neural stem cell proliferation and differentiation. PirB-deficient mice showed an increase in Type 1 neural stem cells, promoting Sox2 and KLF4 gene expression. This suggests a potential therapeutic strategy for elderly or neurodegenerative patients.
Researchers found that miR-513b-5p attenuates autophagy and tumor growth in liver cancer cells by targeting PIK3R3. The study suggests miR-513b-5p as a promising therapeutic target for hepatocellular carcinoma.
Researchers identified a hub candidate network involving RNA binding protein interacting with circular RNA in hepatocellular carcinoma. The study provides insights into the mechanism of HCC and potential biomarker identification.
Researchers investigated eltrombopag's iron chelating properties and their effects on cytarabine antineoplastic activity in pediatric acute myeloid leukemia (AML) cell lines. ELT improves cytarabine's efficacy, reducing viability and increasing apoptosis in AML cells.
Researchers found that esomeprazole inhibits tumor growth and boosts the killing effect of radiation in various cancer cell types. Esomeprazole works by arresting cells in the G1 phase of the cell cycle, thereby limiting their ability to proliferate.
Researchers analyzed association of high-sensitivity C-reactive protein (hsCRP) with breast cancer (BC) by molecular subtype among 296 cases and 259 healthy controls. High hsCRP was associated with increased odds of triple-negative BC, luminal A BC, and HER2-enriched BC.
A study found that a body mass index of 25.0 kg/m2 is the cutoff point for developing type 2 diabetes, with elevated liver enzymes increasing the risk. The research suggests a stronger association between BMI and T2DM when liver enzymes are high, likely due to insulin resistance caused by non-alcoholic fatty liver disease.
Researchers found that pre-treatment T2-weighted MRI texture features can accurately predict the response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. The study identified 7 significant texture features and achieved high classification accuracy using a k-nearest neighbor model.
Prokineticin-1 is a lymphangiogenic factor involved in human colorectal cancer's lymph node metastasis and lymph vessel formation. High PROK1 expression was found to significantly increase the rate of lymph node metastasis.
Researchers investigated the oncogenicity of human LAT1 in NIH/3T3 cells, finding it to be a promising anti-cancer target. Anti-LAT1 monoclonal antibodies inhibited cell proliferation and tumor growth, suggesting LAT1's potential for therapeutic development.
A new droplet digital PCR-based assay for HPV16 circulating tumor DNA was developed to predict treatment response in metastatic head and neck squamous cell carcinoma. Longitudinal changes of HPV16 ctDNA correlate with treatment response, allowing for early identification of treatment failure.
Researchers found that local delivery of tumor-specific T-cells is an efficient option to convert tumors unresponsive to checkpoint inhibitors to permit tumor cures. Locally delivered T-cells showed similar control of established tumors as intravenous adoptive T-cell transfer.
The study confirms the upregulation of TERT in primary glioblastomas and the gradual expression of all GABP components during malignancy progression. The authors found a positive association between TERT and B1L mRNA expression, highlighting the importance of GABPA/B isoforms in mutated TERT promoter-dependent gliomas.
The study shows that the CTD and OD domains of mtp53 R273H play key roles in mutant p53 GOF, pertaining to processes associated with DNA replication. The authors investigated the role of these domains in cell proliferation, DNA replication, and cell cycle progression in breast cancer cells.